Toggle navigation
Toggle navigation
About Inflarx
Leadership Team
Board
R&D
Pipeline
Products & Technology
Technology
Vilobelimab
INF904
IFX002
Clinical Development
Pyoderma Gangraenosum
COVID-19
Clinical Trials
Publications & Posters
Investors
Press Releases
Events & Presentations
Financial Information
Share Information
Analyst Coverage
Corporate Governance
Annual/Extraordinary General Meetings
E-mail alerts
Career
Open Positions
The InflaRx Commitment
World Antimicrobial Resistance Congress
Home
Investors
Events & Presentations
World Antimicrobial Resistance Congress
September 7-8, 2023, Philadelphia, PA, USA
Panel discussion, September 7, 11:20 am EDT with Prof. Niels C. Riedemann, CEO
read more
<< back to list
